Adage Capital Partners Gp, L.L.C. Dexcom Inc Transaction History

Adage Capital Partners Gp, L.L.C.

$51.6 Billion
Q1 2025

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Dexcom Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 15,121 shares of DXCM stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,121

Previous 555,121 97.28%

Holding current value

$1.29 Million

Previous $43.2 Million 97.61%

% of portfolio

0.0%

Previous 0.08%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$67.74 - $90.75 $36.6 Million - $49 Million	-540,000 Reduced 97.28%	15,121 $1.03 Million
Q4 2024 Feb 14, 2025	BUY	$65.68 - $81.01 $471,254 - $581,246	7,175 Added 1.31%	555,121 $43.2 Million
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $10.2 Million - $18.4 Million	158,946 Added 40.86%	547,946 $36.7 Million
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $8.84 Million - $11.3 Million	-80,160 Reduced 17.09%	389,000 $44.1 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $12.1 Million - $14.9 Million	-106,140 Reduced 18.45%	469,160 $65.1 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $14.3 Million - $23.6 Million	189,700 Added 49.2%	575,300 $71.4 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $8.05 Million - $12.9 Million	-93,560 Reduced 19.53%	385,600 $36 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $24.9 Million - $28.9 Million	-220,958 Reduced 31.56%	479,160 $61.6 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $4.45 Million - $5.26 Million	-42,782 Reduced 5.76%	700,118 $81.3 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $15.5 Million - $22.4 Million	182,900 Added 32.66%	742,900 $84.1 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $11.5 Million - $14.2 Million	151,200 Added 36.99%	560,000 $45.1 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $20.9 Million - $40.9 Million	307,625 Added 304.05%	408,800 $30.5 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $197,568 - $273,420	-2,100 Reduced 2.03%	101,175 $51.8 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $64,935 - $81,410	-500 Reduced 0.48%	103,275 $55.5 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $53,355 - $71,590	-500 Reduced 0.48%	103,775 $56.8 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $1.42 Million - $1.89 Million	17,500 Added 20.17%	104,275 $44.5 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $3.38 Million - $4.17 Million	-39,850 Reduced 31.47%	86,775 $31.2 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $1.52 Million - $2.03 Million	19,456 Added 18.15%	126,625 $46.8 Million
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $38,204 - $45,180	400 Added 0.37%	107,169 $44.2 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $2.93 Million - $4.93 Million	46,769 Added 77.95%	106,769 $43.3 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $2.87 Million - $4.54 Million	60,000 New	60,000 $16.2 Million

Others Institutions Holding DXCM

# of Institutions

1,081

Shares Held

363M

Call Options Held

5.4M

Put Options Held

4.3M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Dexcom Inc Transaction History